The Joint Action on Personalised Cancer Medicine (JA PCM) wants to hear your voice!
We are pleased to invite you to the upcoming webinar:
𝐓𝐨𝐰𝐚𝐫𝐝𝐬 𝐚 𝐏𝐮𝐛𝐥𝐢𝐜-𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐢𝐧 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐬𝐞𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐏𝐮𝐛𝐥𝐢𝐜 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬' 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞
We particularly welcome colleagues involved in national and European public initiatives in cancer, personalised medicine, health data and health systems, including representatives of ministries, funding agencies, public health institutes, research infrastructures, regulatory and Health Technology Assessment bodies, and EU-level projects, networks and policy teams.
Following our recent exchange with private sector actors, we now want to hear from the public side to support us in paving the way to a suitable PPP framework that could go beyond JA PCM. Join us for this open discussion to share your opinions, expectations and vision on how a PPP in personalised cancer medicine could be built and what it should achieve. Your input will directly inform the next steps of the dialogue and help ensure that the partnership reflects the needs and priorities of public stakeholders across Europe.
This session is part of a structured dialogue we are building between public and private PCM stakeholders, and we are looking forward to your contribution.
Register here: https://sciensano.webex.com/weblink/register/ra5cbca906b25da206eba51232e6ced65
And do not hesitate to share this invitation with anyone who might be interested!